Denna sida på svenska

Anna-Karin Lindström

Biomedical scientist

Postal address : Department of Neurobiology, Care Sciences and Society (NVS), H1, Division of Neurogeriatrics, Novum Pl 5 14157 Huddinge, Sweden

About me

Biomedical scientist and lab manager, the Brain Bank at Karolinska Institutet


Antemortem Prediction of Braak Stage
Carlson Jo, Gatz M, Pedersen Nl, Graff C, Nennesmo I, Lindström Ak, et al
Journal of neuropathology and experimental neurology 2015;74(11):1061-70

Intracellular fibril formation, calcification, and enrichment of chaperones, cytoskeletal, and intermediate filament proteins in the adult hippocampus CA1 following neonatal exposure to the nonprotein amino acid BMAA
Karlsson O, Berg Al, Hanrieder J, Arnerup G, Lindstrom Ak, Brittebo Eb
ARCHIVES OF TOXICOLOGY 2015;89(3):423-36

Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus
Karlsson O, Berg Al, Lindström Ak, Hanrieder J, Arnerup G, Roman E, et al
Toxicological sciences : an official journal of the Society of Toxicology 2012;130(2):391-404

Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma
Glinghammar B, Rafter I, Lindstrom Ak, Hedberg Jj, Andersson Hb, Lindblom P, et al

Early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity in dogs treated with AR-H047108, an imidazopyridine proton pump inhibitor
Berg Al, Böttcher G, Andersson K, Carlsson E, Lindström Ak, Huby R, et al
Toxicologic pathology 2008;36(5):727-37

Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis
Lundberg I, Kratz Ak, Alexanderson H, Patarroyo M
Arthritis and rheumatism 2000;43(2):336-48